Owners and management
CVR: 46843703
Secondary names: Koblano ApS
Not available
Lyfe Holding ApS (33,33-49,99%), Harryson Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Jens Bo Rode Hansen, Jesper Lykkesfeldt
Board: Jens Bo Rode Hansen (chair) and 2 members
CVR · view management
Active
Founded 5 October 2026
CVR · view overview
No headcount reported
Name registered: Koblano Therapeutics ApS
CVR · 05/10/2026
View the full event history
Koblano Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2026. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Bo Rode Hansen and Jesper Lykkesfeldt. The board consists of Jens Bo Rode Hansen (chair), Jesper Lykkesfeldt and Poul Henrik Bredahl Sørensen. The company is owned by Lyfe Holding ApS, Harryson Holding ApS and Poul Sorensen Biomed Consulting Corp.
Selskabets formål er at drive forskning, udvikling, produktion og salg af medicinske produkter samt hermed forbunden virksomhed.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Koblano Therapeutics ApS is 46843703.
Koblano Therapeutics ApS is owned by Lyfe Holding ApS, Harryson Holding ApS and Poul Sorensen Biomed Consulting Corp.
The management of Koblano Therapeutics ApS consists of Jens Bo Rode Hansen and Jesper Lykkesfeldt.
The board of Koblano Therapeutics ApS consists of Jens Bo Rode Hansen, Jesper Lykkesfeldt and Poul Henrik Bredahl Sørensen, with Jens Bo Rode Hansen as chair.
Koblano Therapeutics ApS was founded on 5 October 2026.
Koblano Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Claim this page to add your logo and social links. Free to get started.
Address changed to Nordre Fasanvej 215, 2000 Frederiksberg (October 26, 2026).
Contact info changed: email: [email protected] -> [email protected] (October 26, 2026).
As of October 5, 2026, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Koblano Therapeutics ApS.
As of October 5, 2026, Jesper Lykkesfeldt has joined the board of directors of Koblano Therapeutics ApS.
As of October 5, 2026, Jens Bo Rode Hansen has joined the board of directors of Koblano Therapeutics ApS.
As of October 5, 2026, Poul Henrik Bredahl Sørensen has joined the board of directors of Koblano Therapeutics ApS.
As of October 5, 2026, Jesper Lykkesfeldt is registered as director of Koblano Therapeutics ApS.
As of October 5, 2026, Jens Bo Rode Hansen is registered as adm. dir. of Koblano Therapeutics ApS.
As of October 5, 2026, Lyfe Holding ApS is registered as an owner of Koblano Therapeutics ApS with an ownership share of 33%.
As of October 5, 2026, Harryson Holding ApS is registered as an owner of Koblano Therapeutics ApS with an ownership share of 33%.
As of October 5, 2026, is registered as an owner of Koblano Therapeutics ApS with an ownership share of 33%.
Koblano Therapeutics ApS was founded on October 5, 2026.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
